The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer
- PMID: 15868235
- DOI: 10.1007/s10350-004-0942-z
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer
Abstract
Purpose: Sphincter-preserving surgery is technically feasible for many rectal cancers, but functional results are not well understood. Therefore, the purpose of this study was to develop an instrument to evaluate bowel function after sphincter-preserving surgery.
Methods: A 41-item bowel function survey was developed from a literature review, expert opinions, and 59 patient interviews. An additional 184 patients who underwent sphincter-preserving surgery between 1997 and 2001 were asked to complete the survey and quality-of-life instruments (Fecal Incontinence Quality of Life, European Organization for Research and Treatment of Cancer QLQ 30/Colorectal Cancer 38). A factor analysis of variance was performed. Test-retest reliability was evaluated, with 20 patients completing two surveys within a mean of 11 days. Validity testing was done with clinical variables (gender, age, radiation, length of time from surgery), surgical variables (procedure: local excision, low anterior resection, coloanal anastomosis), reconstruction (J-pouch, straight), anastomosis (handsewn, stapled), and quality-of-life instruments.
Results: The survey response rate was 70.1 percent (129/184). Among the 127 patients with usable data, 67 percent were male, the median age was 64 (range, 38-87) years, and the mean time for restoration of bowel continuity after sphincter-preserving surgery was 22.9 months. Patients had a median of 3.5 stools/day (range, 0-30), and 37 percent were dissatisfied with their bowel function. Patients experienced a median of 22 symptoms (range, 7-32), with 27 percent reported as severe, 37 percent as moderate, and 36 percent as mild. The five most common symptoms were incomplete evacuation (96.8 percent), clustering (94.4 percent), food affecting frequency (93.2 percent), unformed stool (92.8 percent), and gas incontinence (91.8 percent). The factor analysis identified 14 items that collapsed into three subscales: FREQUENCY (alpha = 0.75), DIETARY (alpha = 0.78), and SOILAGE (alpha = 0.79), with acceptable test-retest reliability for the three subscales and total score (0.62-0.87). The instrument detected differences between patients with preoperative radiation (n = 67) vs. postoperative radiation (n = 15) vs. no radiation (n = 45) (P = 0.02); local excision (n = 10) vs. low anterior resection (n = 55) vs. coloanal anastomosis (n = 62) (P = 0.002); and handsewn (n = 18) vs. stapled anastomosis (n = 99) (P = 0.006). The total score correlated with 4 of 4 Fecal Incontinence Quality of Life (P < 0.01) and 9 of 17 European Organization for Research and Treatment of Cancer subscales (all P < 0.01).
Conclusions: Patients undergoing sphincter-preserving surgery for rectal cancer have impaired bowel function, and those treated with radiation, coloanal anastomoses, or handsewn anastomoses have significantly worse function. This reliable and valid instrument should be used to prospectively evaluate bowel function after sphincter-preserving surgery in patients undergoing rectal cancer therapy.
Similar articles
-
Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument?Ann Surg Oncol. 2007 May;14(5):1727-34. doi: 10.1245/s10434-006-9283-6. Epub 2007 Jan 30. Ann Surg Oncol. 2007. PMID: 17265117
-
Multimedia article. Laparoscopic ultralow anterior resection with colonic J-pouch-anal anastomosis.Dis Colon Rectum. 2008 Nov;51(11):1710-1. doi: 10.1007/s10350-008-9322-4. Epub 2008 Aug 5. Dis Colon Rectum. 2008. PMID: 18679748
-
Late side effects and quality of life after radiotherapy for rectal cancer.Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1005-11. doi: 10.1016/j.ijrobp.2009.03.010. Epub 2009 Jun 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 19540058
-
Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer.Am Surg. 2000 Apr;66(4):387-93. Am Surg. 2000. PMID: 10776877 Review.
-
[Sphincter-preserving surgery for lower rectal cancer aimed at improving postoperative bowel function].Nihon Geka Gakkai Zasshi. 2000 Jun;101(6):459-63. Nihon Geka Gakkai Zasshi. 2000. PMID: 10919155 Review. Japanese.
Cited by
-
Long-term bowel functional outcomes following anal sphincter-preserving surgery for upper and middle rectal cancer: a single-center longitudinal study.Ann Coloproctol. 2024 Feb;40(1):27-35. doi: 10.3393/ac.2022.01067.0152. Epub 2024 Feb 28. Ann Coloproctol. 2024. PMID: 38414121 Free PMC article.
-
The Impact of Dietary Factors on the Relief of Bowel Dysfunction Among Patients with Rectal Cancer After the Sphincter-Saving Surgery-A Prospective Cohort Study.J Gastrointest Cancer. 2024 Jan 19. doi: 10.1007/s12029-023-00997-2. Online ahead of print. J Gastrointest Cancer. 2024. PMID: 38240910
-
Patient Reported Outcome Assessments Used in the Evaluation of Patients after Ileal Pouch-Anal Anastomosis: A Systematic Review.Gastro Hep Adv. 2023;2(8):1044-1049. doi: 10.1016/j.gastha.2023.07.010. Epub 2023 Jul 29. Gastro Hep Adv. 2023. PMID: 38125203 Free PMC article.
-
Clinical Management of Low Anterior Resection Syndrome: Review of the Current Diagnosis and Treatment.Cancers (Basel). 2023 Oct 16;15(20):5011. doi: 10.3390/cancers15205011. Cancers (Basel). 2023. PMID: 37894378 Free PMC article. Review.
-
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).J Clin Oncol. 2023 Jul 20;41(21):3724-3734. doi: 10.1200/JCO.23.00903. Epub 2023 Jun 4. J Clin Oncol. 2023. PMID: 37270691 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical